QCG
LEGN icon

Quadrant Capital Group’s Legend Biotech LEGN Stock Holding History

Quadrant Capital Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Sell
1,959
-291
-13% -$5.55K ﹤0.01% 1811
2025
Q4 		$48.9K Sell
2,250
-23,291
-91% -$667K ﹤0.01% 1689
2025
Q3 		$833K Buy
25,541
+12,716
+99% +$469K 0.03% 599
2025
Q2 		$455K Buy
12,825
+8,787
+218% +$285K 0.02% 929
2025
Q1 		$137K Buy
4,038
+213
+6% +$7.64K 0.01% 1441
2024
Q4 		$124K Buy
3,825
+3,738
+4,297% +$155K 0.01% 936
2024
Q3 		$4.24K Buy
87
+16
+23% +$852 ﹤0.01% 2355
2024
Q2 		$3.15K Buy
71
+8
+13% +$369 ﹤0.01% 2402
2024
Q1 		$3.53K Sell
63
-8
-11% -$482 ﹤0.01% 2398
2023
Q4 		$4.27K Buy
71
+48
+209% +$3.04K ﹤0.01% 2321
2023
Q3 		$1.54K Hold
23
– – ﹤0.01% 2443
2023
Q2 		$1.59K Hold
23
– – ﹤0.01% 2456
2023
Q1 		$1.11K Buy
23
+10
+77% +$489 ﹤0.01% 2534
2022
Q4 		$649 Buy
13
+5
+63% +$242 ﹤0.01% 2591
2022
Q3 		$0 Buy
+8
New +$375 ﹤0.01% 2728
2022
Q1 		– Sell
-214
Closed -$10K – 2599
2021
Q4 		$10K Sell
214
-66
-24% -$3.35K ﹤0.01% 1628
2021
Q3 		$14K Hold
280
– – ﹤0.01% 1426
2021
Q2 		$11K Hold
280
– – ﹤0.01% 1510
2021
Q1 		$8K Buy
280
+80
+40% +$2.18K ﹤0.01% 1607
2020
Q4 		$6K Hold
200
– – ﹤0.01% 1637
2020
Q3 		$6K Buy
+200
New +$6.73K ﹤0.01% 1464

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quadrant Capital Group's LEGN Position: Q1 2026 in Review

Quadrant Capital Group reduced its Legend Biotech (LEGN) stake by 13% in Q1 2026, selling an estimated $5.55K and leaving 1,959 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

Quadrant Capital Group first reported a position in LEGN in Q3 2020 and has held it in 21 quarters since. The position peaked at $833K in Q3 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Quadrant Capital Group held 1,959 shares of Legend Biotech worth $35.4K as of Q1 2026.
  • Quadrant Capital Group sold 291 Legend Biotech shares in Q1 2026, an estimated $5.55K.
  • Legend Biotech made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1811 holding.
  • Quadrant Capital Group first reported a position in Legend Biotech in Q3 2020 and has held it in 21 quarters since.
  • Quadrant Capital Group's Legend Biotech position peaked at $833K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.